ArticleLeukemia2025
VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target.
Ophélie Champion et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleLeukemia2025
Ophélie Champion et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.